{"filing":{"accession_number":"0001459839-26-000076","cik":"0001459839","ticker":"SIBN","company_name":"SI-BONE, Inc.","form":"8-K","filing_date":"2026-09-11","report_date":"2026-08-21","primary_document":"sibn-20260821.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1459839/000145983926000076/sibn-20260821.htm"},"events":[{"id":32924,"run_id":30270,"accession_number":"0001459839-26-000076","anchor_item_number":"2.03","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"SI-BONE entered into a material definitive agreement creating a new direct financial obligation, as disclosed through Item 2.03's incorporation by reference of Item 1.01. This represents a debt issuance, credit facility, or similar financial obligation material to the registrant's capital structure.","company_name":"SI-BONE, Inc.","ticker":"SIBN","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36216,"accession_number":"0001459839-26-000076","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"operational_other","event_domain":"operational","is_material":false,"confidence":0.75,"reasoning":"This disclosure concerns a one-month extension of an existing office lease for the Company's corporate headquarters at 471 El Camino Real, Santa Clara, California. While Item 1.01 requires disclosure of material definitive agreements, a routine one-month lease extension with base rent of $43,696 per month is an ordinary operational matter that would not affect a reasonable investor's assessment of the registrant's financial condition or prospects. The extension is administrative in nature and does not signal any material business development, financial stress, or strategic change.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:07:04.086386+00:00","company_name":"","ticker":null,"filing_date":""},{"id":36217,"accession_number":"0001459839-26-000076","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation. The filing incorporates Item 1.01 (Entry into a Material Definitive Agreement) by reference, indicating SI-BONE has entered into a material agreement creating a new financial obligation—typically a debt issuance, credit facility, or term loan. This is material to investors as it affects the registrant's capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:07:04.086386+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":32925,"run_id":30270,"accession_number":"0001459839-26-000076","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"SI-BONE initiated a voluntary recall of 98 iFuse TORQ implants due to tube packaging failure compromising sterile barrier integrity, with approximately 3,900 additional implants requiring repackaging and re-sterilization. The company expects to record up to $150,000 in charges in Q3-Q4 and submitted a Class II recall report to the FDA.","company_name":"SI-BONE, Inc.","ticker":"SIBN","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36218,"accession_number":"0001459839-26-000076","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"SI-BONE initiated a voluntary recall of 98 iFuse TORQ implants due to tube packaging failure that compromised sterile barrier integrity, with approximately 3,900 additional implants requiring repackaging and re-sterilization. The company expects to record up to $150,000 in charges in Q3-Q4 and submitted a Class II recall report to the FDA. This is a material operational and product quality event involving regulatory action, product recall, and quantifiable financial impact, but does not fit the specific categories of material_litigation, cybersecurity_incident, or other named types—it is a product quality/recall matter best classified as operational_other.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:07:04.086386+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36216,"accession_number":"0001459839-26-000076","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"operational_other","event_domain":"operational","is_material":false,"confidence":0.75,"reasoning":"This disclosure concerns a one-month extension of an existing office lease for the Company's corporate headquarters at 471 El Camino Real, Santa Clara, California. While Item 1.01 requires disclosure of material definitive agreements, a routine one-month lease extension with base rent of $43,696 per month is an ordinary operational matter that would not affect a reasonable investor's assessment of the registrant's financial condition or prospects. The extension is administrative in nature and does not signal any material business development, financial stress, or strategic change.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:07:04.086386+00:00","company_name":"SI-BONE, Inc.","ticker":"SIBN","filing_date":"2026-09-11"},{"id":36217,"accession_number":"0001459839-26-000076","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 explicitly addresses creation of a direct financial obligation. The filing incorporates Item 1.01 (Entry into a Material Definitive Agreement) by reference, indicating SI-BONE has entered into a material agreement creating a new financial obligation—typically a debt issuance, credit facility, or term loan. This is material to investors as it affects the registrant's capital structure and financial obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:07:04.086386+00:00","company_name":"SI-BONE, Inc.","ticker":"SIBN","filing_date":"2026-09-11"},{"id":36218,"accession_number":"0001459839-26-000076","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"SI-BONE initiated a voluntary recall of 98 iFuse TORQ implants due to tube packaging failure that compromised sterile barrier integrity, with approximately 3,900 additional implants requiring repackaging and re-sterilization. The company expects to record up to $150,000 in charges in Q3-Q4 and submitted a Class II recall report to the FDA. This is a material operational and product quality event involving regulatory action, product recall, and quantifiable financial impact, but does not fit the specific categories of material_litigation, cybersecurity_incident, or other named types—it is a product quality/recall matter best classified as operational_other.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:07:04.086386+00:00","company_name":"SI-BONE, Inc.","ticker":"SIBN","filing_date":"2026-09-11"}]}